![Paul A. Barsanti](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul A. Barsanti
Directeur Technique/Scientifique/R&D chez
IDEAYA BIOSCIENCES, INC.
Profil
Paul A. Barsanti is Chief Technology Officer at IDEAYA Biosciences, Inc. since 2023.
Formerly, Dr. Barsanti was Head-Chemistry at Nurix Therapeutics, Inc. from 2014 to 2018.
Education includes an undergraduate degree conferred in 1993 and a doctorate conferred in 1996, both from the University of Bath.
Postes actifs de Paul A. Barsanti
| Sociétés | Poste | Début |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | 01/03/2023 |
Anciens postes connus de Paul A. Barsanti
| Sociétés | Poste | Fin |
|---|---|---|
| NURIX THERAPEUTICS, INC. | Corporate Officer/Principal | 01/06/2018 |
Formation de Paul A. Barsanti
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Nurix Therapeutics, Inc.
 Nurix Therapeutics, Inc. BiotechnologyHealth Technology Operates as a a clinical stage biopharmaceutical company that discovers, develops and commercializes oral, small molecule therapies for the treatment of cancer & immune disorders | Health Technology |
University of Bath
 University of Bath Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IDEAYA Biosciences, Inc.
 IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
